We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $2.64M invested in Seelos Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 6 → 10 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

53% less capital invested

Capital invested by funds: $5.59M → $2.64M (-$2.95M)

Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$3.06M
2
AC
Armistice Capital
New York
+$1.91M
3
Renaissance Technologies
Renaissance Technologies
New York
+$383K
4
Citadel Advisors
Citadel Advisors
Florida
+$191K
5
Squarepoint
Squarepoint
New York
+$191K

Top Sellers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
-$64K
2
OAM
Oxford Asset Management
United Kingdom
-$53K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$21K
4
CF
Centaurus Financial
California
-$18K
5
EWM
Evercore Wealth Management
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$796K +$1.91M +10 +143%
SM
2
Sabby Management
Florida
$731K +$3.06M +16 New
SCM
3
Sarissa Capital Management
Connecticut
$587K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$189K +$191K +1 +33%
Renaissance Technologies
5
Renaissance Technologies
New York
$71K +$383K +2 New
Citadel Advisors
6
Citadel Advisors
Florida
$63K +$191K +1 New
HVC
7
Healthcare Value Capital
New Jersey
$41K – – –
BlackRock
8
BlackRock
New York
$36K – – –
Franklin Resources
9
Franklin Resources
California
$33K – – –
Squarepoint
10
Squarepoint
New York
$29K +$191K +1 New
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$14.7K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$10K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$10K – – –
Northern Trust
14
Northern Trust
Illinois
$6K – – –
CS
15
Credit Suisse
Switzerland
$5K – – –
CG
16
Colony Group
Massachusetts
$4K – – –
MML Investors Services
17
MML Investors Services
Massachusetts
$4K – – –
VF
18
Virtu Financial
New York
$4K – – –
FANJ
19
Financial Architects (New Jersey)
New Jersey
$1K – – –
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
– -$21K – –
BIP
22
Brandes Investment Partners
California
– -$64K – –
CF
23
Centaurus Financial
California
– -$18K – –
Citigroup
24
Citigroup
New York
– -$4K – –
EWM
25
Evercore Wealth Management
New York
– -$5K – –
1
2

SEEL Hedge Fund Activity: Q1 2018 in Review

10 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2018, worth a combined $2.64M — down 53% from $5.59M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SEEL positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.06M. The largest seller was Brandes Investment Partners, cutting an estimated $64K.

  • 10 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2018, up from 6 in Q4 2017.
  • Funds reported $2.64M of Seelos Therapeutics, Inc. Common Stock stock for Q1 2018, down 53% quarter-over-quarter.
  • 4 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2018 and 0 closed out, a net change of +4 holders.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q1 2018 was Sabby Management, an estimated $3.06M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2018 was Brandes Investment Partners, an estimated $64K sold.

Based on aggregated 13F filings for Q1 2018.